Cosuppression of NF-κB and AICDA Overcomes Acquired EGFR-TKI Resistance in Non-Small Cell Lung Cancer.

Autor: Yeo, Min-Kyung¹ (AUTHOR) mkyeo83@gmail.com, Kim, Yoonjoo² (AUTHOR) k1206j@cnuh.co.kr, Lee, Da Hye² (AUTHOR) ziczi02@naver.com, Chung, Chaeuk² (AUTHOR) universe7903@gmail.com, Bae, Go Eun¹ (AUTHOR) universe7903@gmail.com

Publikováno v: Cancers. Jun2022, Vol. 14 Issue 12, p2940-N.PAG. 11p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Hyper‐IgM syndrome resulting from heterozygous AICDA variants: A European first?

Autor: Kacar, Mark¹ (AUTHOR), Shrimpton, Jennifer K.² (AUTHOR), Jassam, Miriam¹ (AUTHOR), Mistry, Anoop¹ (AUTHOR), Arumugakani, Gururaj¹ (AUTHOR), Grammatikos, Alexandros³ (AUTHOR), Gompels, Mark³ (AUTHOR), Doody, Gina M.² (AUTHOR), Savic, Sinisa^1,4 (AUTHOR) s.savic@leeds.ac.uk

Publikováno v: Scandinavian Journal of Immunology. Jul2022, Vol. 96 Issue 1, p1-4. 4p.

A Novel Heterozygous Variant in AICDA Impairs Ig Class Switching and Somatic Hypermutation in Human B Cells and is Associated with Autosomal Dominant HIGM2 Syndrome.

Autor: Della Mina E; Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, NSW, 2010, Australia.; School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia., Jackson KJL; Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, NSW, 2010, Australia., Crawford AJI; Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, NSW, 2010, Australia., Faulks ML; Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, NSW, 2010, Australia., Pathmanandavel K; Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, NSW, 2010, Australia.; School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia., Acquarola N; Department of Clinical Immunology and PathWest, Fiona Stanley Hospital, Murdoch, WA, Australia., O'Sullivan M; Department of Clinical Immunology and PathWest, Fiona Stanley Hospital, Murdoch, WA, Australia.; Department of Immunology, Perth Children's Hospital, Perth, WA, Australia., Kerre T; Department of Hematology, Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.; Center for Primary Immunodeficiency Ghent (CPIG), Jeffrey Modell Diagnosis and Research Center, ERN Rita Network Center, Ghent University Hospital, Ghent, Belgium., Naesens L; Center for Primary Immunodeficiency Ghent (CPIG), Jeffrey Modell Diagnosis and Research Center, ERN Rita Network Center, Ghent University Hospital, Ghent, Belgium.; Primary Immunodeficiency Research Lab, Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium., Claes K; Center for Primary Immunodeficiency Ghent (CPIG), Jeffrey Modell Diagnosis and Research Center, ERN Rita Network Center, Ghent University Hospital, Ghent, Belgium.; Primary Immunodeficiency Research Lab, Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium., Goodnow CC; Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, NSW, 2010, Australia.; School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia., Haerynck F; Center for Primary Immunodeficiency Ghent (CPIG), Jeffrey Modell Diagnosis and Research Center, ERN Rita Network Center, Ghent University Hospital, Ghent, Belgium.; Primary Immunodeficiency Research Lab, Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium., Kracker S; Laboratory of Human Lymphohematopoiesis, INSERM UMR 1163, Imagine Institute, 75015, Paris, France.; Université Paris Cité, 75015, Paris, France., Meyts I; Inborn Errors of Immunity, Department of Microbiology, Immunology and Transplantation, KU Leuven, Louvain, Belgium.; Pediatric Immunodeficiency, Department of Pediatrics, University Hospitals Leuven, Louvain, Belgium., D'Orsogna LJ; Department of Clinical Immunology and PathWest, Fiona Stanley Hospital, Murdoch, WA, Australia.; School of Medicine, University of Western Australia, Nedlands, WA, Australia., Ma CS; Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, NSW, 2010, Australia.; School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia., Tangye SG; Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, NSW, 2010, Australia. s.tangye@garvan.org.au.; School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia. s.tangye@garvan.org.au.

Publikováno v: Journal of clinical immunology [J Clin Immunol] 2024 Feb 16; Vol. 44 (3), pp. 66. Date of Electronic Publication: 2024 Feb 16.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.